Evidence map›Paper›PMID 25042164›Full record

ReviewCritical care (London, England)2014

Albumin administration in the acutely ill: what is new and where next?

Jean-Louis Vincent, James A Russell, Matthias Jacob, Greg Martin, Bertrand Guidet, Jan Wernerman, Ricard Ferrer, Ricard Ferrer Roca, Stuart A McCluskey, Luciano Gattinoni

Erratum issued Registry-linked trialOpen access · goldAbstract readHistorical ArticleReview
In one paragraph

Review in Critical care (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04058236 (Glycocalyx Levels in Patients Undergoing Pancreatectomy With Human Albumin 5% vs. Gelofusine), which is not on this map. Cited by 117 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04058236 phase4unknown statusnot on this mapstarted 2019, after this paper: background citation

Glycocalyx Levels in Patients Undergoing Pancreatectomy With Human Albumin 5% vs. Gelofusine

TypeinterventionalSponsorUniversity of MalayaRan2019 to 2021Enrolled20ConditionsEndothelial Degeneration, Pancreatic Cancer, Pancreatectomy, Postoperative Pancreatic FistulaArmshuman albumin 5%, gelofusine.
3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 1 synthesis or guideline pooled it, 282 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Roca, Ricard Ferrer [corrected to Ferrer, Ricard]
5 · Who and what money

Authors and funding

10 authors at 8 institutions in 7 countries.

Jean-Louis Vincent
James A Russell
Matthias Jacob
Greg Martin
Bertrand Guidet
Jan Wernerman
Ricard Ferrer
Ricard Ferrer Roca
Stuart A McCluskey
Luciano Gattinoni
Emory University · USHôpital Saint-Antoine · FRIstituti di Ricovero e Cura a Carattere Scientifico · ITKarolinska University Hospital · SEUniversitat de Barcelona · ESUniversité Libre de Bruxelles · BEUniversity of British Columbia · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Albumin solutions have been used worldwide for the treatment of critically ill patients since they became commercially available in the 1940s. However, their use has become the subject of criticism and debate in more recent years. Importantly, all fluid solutions have potential benefits and drawbacks. Large multicenter randomized studies have provided valuable data regarding the safety of albumin solutions, and have begun to clarify which groups of patients are most likely to benefit from their use. However, many questions remain related to where exactly albumin fits within our fluid choices. Here, we briefly summarize some of the physiology and history of albumin use in intensive care before offering some evidence-based guidance for albumin use in critically ill patients.

Indexed as

AlbuminsBrain InjuriesClinical Trials as TopicCost-Benefit AnalysisCritical CareCritical IllnessFluid TherapyHistory, 20th CenturyHumansHypoalbuminemiaResuscitationSepsisAlbumins

Identifiers

PMID25042164
PMCPMC4223404
OpenAlexW2142381802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.